Physician profile
Phillip D Stephenson
NPI 1922235019
$4,138.04
in general payments reported to CMS, 2019-2025
5 companies · $370 in 2025
The $370 reported for 2025 was more than what 86% of Cytopathology providers received nationally (typical 2025 total: $55.75).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $53.27 · 2020: $13.67 · 2021: $39.67 · 2022: $1,133 · 2023: $554 · 2024: $1,974 · 2025: $370.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,186 · Food and Beverage: $712.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,186.08 |
| Food and Beverage | $711.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Becton, Dickinson and Company | $3,377.42 | 2019-2025 | Bd Onclarity, Bd Max System, Bd Max Instrument, Bd Geneohm Staphsr Assay 48 Testsa |
| C. R. Bard, INC. & Subsidiaries | $652.47 | 2022-2024 | Bd Viper System |
| Merck Sharp & Dohme LLC | $69.25 | 2022-2025 | Keytruda, Lynparza |
| Astrazeneca Pharmaceuticals Lp | $25.30 | 2025 | |
| Abbott Laboratories | $13.60 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Phillip Stephenson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.